Japanese pharma giant Kyowa Kirin is set to receive $400 million in a deal that wouldn’t have happened without the company’s San Diego lab. The company recently announced a partnership with Amgen to develop a drug against eczema, a skin condition that can leave painful and itchy rashes across your hands, feet and behind your […]

Aethlon Medical’s stock surged Wednesday, fueled by excitement around a device the company is developing to treat COVID-19 patients by removing the novel coronavirus from their blood. Shares in Aethlon closed Wednesday at $10.79, up 388 percent from Tuesday’s close of $2.21 on the Nasdaq exchange. Trading volume ballooned as well, with nearly 250 million […]

DocWire News with spoke with Mike Clayman, M.D., CEO at Flexion Therapeutics, a company focused on the development of novel, local therapies for the treatment of musculoskeletal conditions – with one approved drug – ZILRETTA® for osteoarthritis knee pain. See what Dr. Clayman had to say about these therapies.